SHEILA GENDICH: Open Payments
NPI 1124018536 · IONIA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,216 in 134 payments from 24 companies in 2025. Trend: 2023 $1,413 · 2024 $1,597 · 2025 $2,216
Food & beverage: $2,216
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 31 | $357 |
| Kowa Pharmaceuticals America, Inc. | 14 | $274 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $263 |
| ABBVIE INC. | 19 | $242 |
| Otsuka America Pharmaceutical, Inc. | 11 | $192 |
| Axsome Therapeutics, Inc. | 7 | $159 |
| Alkermes, Inc. | 4 | $109 |
| Lundbeck LLC | 3 | $88 |
| Xeris Pharmaceuticals, Inc. | 3 | $67 |
| Braeburn Inc. | 4 | $66 |
Products named: Qelbree, REXULTI, ZORYVE, CAPLYTA, Auvelity, ARISTADA, CREON, BRIXADI.
Industry payments across MI — which companies pay providers there.
